| Year |
Citation |
Score |
| 2019 |
Lee MH, Gallo PM, Hooper KM, Corradetti C, Ganea D, Caricchio R, Gallucci S. The cytokine network type I IFN-IL-27-IL-10 is augmented in murine and human lupus. Journal of Leukocyte Biology. PMID 31216373 DOI: 10.1002/Jlb.3Ab0518-180Rr |
0.386 |
|
| 2018 |
Li H, Kong W, Chambers CR, Yu D, Ganea D, Tuma RF, Ward SJ. The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice. Cellular Immunology. PMID 29784129 DOI: 10.1016/J.Cellimm.2018.02.016 |
0.544 |
|
| 2017 |
Hooper KM, Kong W, Ganea D. Prostaglandin E2 inhibits Tr1 cell differentiation through suppression of c-Maf. Plos One. 12: e0179184. PMID 28604806 DOI: 10.1371/Journal.Pone.0179184 |
0.651 |
|
| 2017 |
Ohtake Y, Kong W, Hussain R, Horiuchi M, Tremblay ML, Ganea D, Li S. Protein tyrosine phosphatase σ regulates autoimmune encephalomyelitis development. Brain, Behavior, and Immunity. PMID 28559011 DOI: 10.1016/J.Bbi.2017.05.018 |
0.644 |
|
| 2017 |
Hooper KM, Yen JH, Kong W, Rahbari KM, Kuo PC, Gamero AM, Ganea D. Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1. Journal of Immunology (Baltimore, Md. : 1950). PMID 28062696 DOI: 10.4049/Jimmunol.1601073 |
0.653 |
|
| 2016 |
Kong W, Hooper KM, Ganea D. The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation. Brain, Behavior, and Immunity. 53: 59-71. PMID 26541818 DOI: 10.1016/J.Bbi.2015.11.002 |
0.64 |
|
| 2015 |
Yen JH, Kong W, Hooper KM, Emig F, Rahbari KM, Kuo PC, Scofield BA, Ganea D. Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells. Journal of Leukocyte Biology. PMID 26059829 DOI: 10.1189/Jlb.3Hi0914-453R |
0.607 |
|
| 2015 |
Ganea D, Hooper KM, Kong W. The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases. Acta Physiologica (Oxford, England). 213: 442-52. PMID 25422088 DOI: 10.1111/Apha.12427 |
0.613 |
|
| 2014 |
Newman TN, Liverani E, Ivanova E, Russo GL, Carpino N, Ganea D, Safadi F, Kunapuli SP, Tsygankov AY. Members of the novel UBASH3/STS/TULA family of cellular regulators suppress T-cell-driven inflammatory responses in vivo. Immunology and Cell Biology. 92: 837-50. PMID 25047644 DOI: 10.1038/Icb.2014.60 |
0.403 |
|
| 2014 |
Kong W, Li H, Tuma RF, Ganea D. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS. Cellular Immunology. 287: 1-17. PMID 24342422 DOI: 10.1016/J.Cellimm.2013.11.002 |
0.636 |
|
| 2014 |
Pedreño M, Morell M, Robledo G, Souza-Moreira L, Forte-Lago I, Caro M, O'Valle F, Ganea D, Gonzalez-Rey E. Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels. Brain, Behavior, and Immunity. 37: 152-63. PMID 24321213 DOI: 10.1016/J.Bbi.2013.11.021 |
0.497 |
|
| 2013 |
Yen JH, Xu S, Park YS, Ganea D, Kim KC. Higher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses. Brain, Behavior, and Immunity. 29: 70-81. PMID 23261777 DOI: 10.1016/J.Bbi.2012.12.004 |
0.431 |
|
| 2013 |
Delgado M, Ganea D. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino Acids. 45: 25-39. PMID 22139413 DOI: 10.1007/S00726-011-1184-8 |
0.437 |
|
| 2013 |
Ganea D, Toscano M, Emig F, Hooper K. 48. Neuropeptides as cell gene therapy in experimental autoimmune encephalomyelitis Brain Behavior and Immunity. 32. DOI: 10.1016/J.Bbi.2013.07.060 |
0.532 |
|
| 2012 |
Nishimori JH, Newman TN, Oppong GO, Rapsinski GJ, Yen JH, Biesecker SG, Wilson RP, Butler BP, Winter MG, Tsolis RM, Ganea D, Tükel Ç. Microbial amyloids induce interleukin 17A (IL-17A) and IL-22 responses via Toll-like receptor 2 activation in the intestinal mucosa. Infection and Immunity. 80: 4398-408. PMID 23027540 DOI: 10.1128/Iai.00911-12 |
0.43 |
|
| 2012 |
Kocieda VP, Adhikary S, Emig F, Yen JH, Toscano MG, Ganea D. Prostaglandin E2-induced IL-23p19 subunit is regulated by cAMP-responsive element-binding protein and C/AATT enhancer-binding protein β in bone marrow-derived dendritic cells. The Journal of Biological Chemistry. 287: 36922-35. PMID 22977257 DOI: 10.1074/Jbc.M112.402958 |
0.725 |
|
| 2012 |
Adhikary S, Kocieda VP, Yen JH, Tuma RF, Ganea D. Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression. Blood. 120: 3741-9. PMID 22972984 DOI: 10.1182/Blood-2012-06-435362 |
0.743 |
|
| 2011 |
Adhikary S, Li H, Heller J, Skarica M, Zhang M, Ganea D, Tuma RF. Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury. Journal of Neurotrauma. 28: 2417-27. PMID 21970496 DOI: 10.1089/Neu.2011.1853 |
0.571 |
|
| 2011 |
Yen JH, Kocieda VP, Jing H, Ganea D. Prostaglandin E2 induces matrix metalloproteinase 9 expression in dendritic cells through two independent signaling pathways leading to activator protein 1 (AP-1) activation. The Journal of Biological Chemistry. 286: 38913-23. PMID 21940623 DOI: 10.1074/Jbc.M111.252932 |
0.753 |
|
| 2011 |
Ganea D, Kocieda V, Kong W, Yen JH. Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation. Clinical Lipidology. 6: 277-291. PMID 21804863 DOI: 10.2217/Clp.11.12 |
0.726 |
|
| 2011 |
Toscano MG, Ganea D, Gamero AM. Cecal ligation puncture procedure. Journal of Visualized Experiments : Jove. PMID 21587163 DOI: 10.3791/2860 |
0.331 |
|
| 2011 |
Kong W, Yen JH, Ganea D. Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 25: 872-82. PMID 20854895 DOI: 10.1016/J.Bbi.2010.09.012 |
0.669 |
|
| 2010 |
Gonzalez-Rey E, Ganea D, Delgado M. Neuropeptides: keeping the balance between pathogen immunity and immune tolerance. Current Opinion in Pharmacology. 10: 473-81. PMID 20399708 DOI: 10.1016/J.Coph.2010.03.003 |
0.348 |
|
| 2010 |
Yen JH, Kong W, Ganea D. IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. Journal of Immunology (Baltimore, Md. : 1950). 184: 3478-86. PMID 20190134 DOI: 10.4049/Jimmunol.0902542 |
0.628 |
|
| 2010 |
Kong W, Yen JH, Vassiliou E, Adhikary S, Toscano MG, Ganea D. Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family. Lipids in Health and Disease. 9: 12. PMID 20122166 DOI: 10.1186/1476-511X-9-12 |
0.719 |
|
| 2010 |
Toscano MG, Delgado M, Kong W, Martin F, Skarica M, Ganea D. Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1035-45. PMID 20068554 DOI: 10.1038/Mt.2009.293 |
0.681 |
|
| 2009 |
Heller JE, Baty DE, Zhang M, Li H, Adler M, Ganea D, Gaughan J, Loftus CM, Jallo JI, Tuma RF. The combination of selective inhibition of the cannabinoid CB1-, receptor and activation of the cannabinoid CB2 receptor yields improved attenuation of motor and autonomic deficits in a mouse model of Spinal Cord Injury Clinical Neurosurgery. 56: 84-92. PMID 20214038 DOI: 10.1227/01.Neu.0000333487.18324.36 |
0.307 |
|
| 2009 |
Yen JH, Ganea D. Interferon beta induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation. Blood. 114: 1344-54. PMID 19531658 DOI: 10.1182/Blood-2008-12-196592 |
0.457 |
|
| 2009 |
Zhang M, Martin BR, Adler MW, Razdan RJ, Kong W, Ganea D, Tuma RF. Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 4: 249-59. PMID 19255856 DOI: 10.1007/S11481-009-9148-4 |
0.591 |
|
| 2008 |
Vassiliou EK, Kesler OM, Tadros JH, Ganea D. Bone marrow-derived dendritic cells generated in the presence of resolvin E1 induce apoptosis of activated CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 181: 4534-44. PMID 18802056 DOI: 10.4049/Jimmunol.181.7.4534 |
0.547 |
|
| 2008 |
Delgado M, Ganea D. Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents. Brain, Behavior, and Immunity. 22: 1146-51. PMID 18598752 DOI: 10.1016/J.Bbi.2008.06.001 |
0.417 |
|
| 2008 |
Khayrullina T, Yen JH, Jing H, Ganea D. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. Journal of Immunology (Baltimore, Md. : 1950). 181: 721-35. PMID 18566439 |
0.408 |
|
| 2008 |
Zhang M, Martin BR, Adler MW, Razdan RK, Ganea D, Tuma RF. Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury. Neuroscience. 152: 753-60. PMID 18304750 DOI: 10.1016/J.Neuroscience.2008.01.022 |
0.31 |
|
| 2008 |
Yen JH, Khayrullina T, Ganea D. PGE2-induced metalloproteinase-9 is essential for dendritic cell migration. Blood. 111: 260-70. PMID 17925490 DOI: 10.1182/blood-2007-05-090613 |
0.389 |
|
| 2008 |
Ganea D. Neuropeptides: active participants in regulation of immune responses in the CNS and periphery. Brain, Behavior, and Immunity. 22: 33-4. PMID 17706916 DOI: 10.1016/J.Bbi.2007.06.014 |
0.46 |
|
| 2007 |
Sheibanie AF, Khayrullina T, Safadi FF, Ganea D. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis. Arthritis and Rheumatism. 56: 2608-19. PMID 17665454 DOI: 10.1002/Art.22794 |
0.379 |
|
| 2007 |
Sheibanie AF, Yen JH, Khayrullina T, Emig F, Zhang M, Tuma R, Ganea D. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis. Journal of Immunology (Baltimore, Md. : 1950). 178: 8138-47. PMID 17548652 DOI: 10.4049/Jimmunol.178.12.8138 |
0.308 |
|
| 2007 |
Liu L, Yen JH, Ganea D. A novel VIP signaling pathway in T cells cAMP-->protein tyrosine phosphatase (SHP-2?)-->JAK2/STAT4-->Th1 differentiation. Peptides. 28: 1814-24. PMID 17462790 DOI: 10.1016/J.Peptides.2007.03.015 |
0.464 |
|
| 2006 |
Ganea D, Gonzalez-Rey E, Delgado M. A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 1: 400-9. PMID 18040812 DOI: 10.1007/S11481-006-9044-0 |
0.492 |
|
| 2006 |
Delgado M, Gonzalez-Rey E, Ganea D. Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis. Annals of the New York Academy of Sciences. 1070: 233-8. PMID 16888172 DOI: 10.1196/Annals.1317.020 |
0.497 |
|
| 2006 |
Gonzalez-Rey E, Varela N, Sheibanie AF, Chorny A, Ganea D, Delgado M. Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. Proceedings of the National Academy of Sciences of the United States of America. 103: 4228-33. PMID 16537513 DOI: 10.1073/Pnas.0508997103 |
0.443 |
|
| 2006 |
Chorny A, Gonzalez-Rey E, Fernandez-Martin A, Ganea D, Delgado M. Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response. Blood. 107: 3787-94. PMID 16418327 DOI: 10.1182/Blood-2005-11-4495 |
0.378 |
|
| 2005 |
Delgado M, Gonzalez-Rey E, Ganea D. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 175: 7311-24. PMID 16301637 DOI: 10.4049/Jimmunol.175.11.7311 |
0.519 |
|
| 2004 |
Vassiliou E, Sharma V, Jing H, Sheibanie F, Ganea D. Prostaglandin E2 promotes the survival of bone marrow-derived dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 173: 6955-64. PMID 15557192 |
0.334 |
|
| 2004 |
Jing H, Yen JH, Ganea D. A novel signaling pathway mediates the inhibition of CCL3/4 expression by prostaglandin E2. The Journal of Biological Chemistry. 279: 55176-86. PMID 15498767 DOI: 10.1074/jbc.M409816200 |
0.376 |
|
| 2004 |
Delgado M, Gonzalez-Rey E, Ganea D. VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1453-5. PMID 15231725 DOI: 10.1096/Fj.04-1548Fje |
0.493 |
|
| 2004 |
Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1318-20. PMID 15180965 DOI: 10.1096/fj.03-1367fje |
0.371 |
|
| 2003 |
Vassiliou E, Jing H, Ganea D. Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cellular Immunology. 223: 120-32. PMID 14527510 |
0.344 |
|
| 2003 |
Jing H, Vassiliou E, Ganea D. Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells. Journal of Leukocyte Biology. 74: 868-79. PMID 12960284 DOI: 10.1189/jlb.0303116 |
0.389 |
|
| 2003 |
Delgado M, Abad C, Martinez C, Juarranz MG, Leceta J, Ganea D, Gomariz RP. PACAP in immunity and inflammation. Annals of the New York Academy of Sciences. 992: 141-57. PMID 12794054 |
0.337 |
|
| 2002 |
Delgado M, Jonakait GM, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia. Glia. 39: 148-61. PMID 12112366 DOI: 10.1002/Glia.10098 |
0.379 |
|
| 2002 |
Kim WK, Ganea D, Jonakait GM. Inhibition of microglial CD40 expression by pituitary adenylate cyclase-activating polypeptide is mediated by interleukin-10. Journal of Neuroimmunology. 126: 16-24. PMID 12020953 DOI: 10.1016/S0165-5728(02)00059-0 |
0.35 |
|
| 2002 |
Delgado M, Ganea D. Inhibition of endotoxin-induced macrophage chemokine production by VIP and PACAP in vitro and in vivo. Archives of Physiology and Biochemistry. 109: 377-82. PMID 11935377 DOI: 10.1076/apab.109.4.377.4237 |
0.373 |
|
| 2002 |
Vassiliou E, Jiang X, Delgado M, Ganea D. TH2 lymphocytes secrete functional VIP upon antigen stimulation. Archives of Physiology and Biochemistry. 109: 365-8. PMID 11935374 DOI: 10.1076/Apab.109.4.365.4245 |
0.45 |
|
| 2001 |
Delgado M, Ganea D. Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo. Journal of Immunology (Baltimore, Md. : 1950). 167: 966-75. PMID 11441105 DOI: 10.4049/jimmunol.167.2.966 |
0.385 |
|
| 2001 |
Ganea D, Delgado M. Inhibitory neuropeptide receptors on macrophages. Microbes and Infection. 3: 141-7. PMID 11251300 DOI: 10.1016/S1286-4579(00)01361-7 |
0.319 |
|
| 2001 |
Delgado M, Ganea D. Cutting edge: is vasoactive intestinal peptide a type 2 cytokine? Journal of Immunology (Baltimore, Md. : 1950). 166: 2907-12. PMID 11207237 DOI: 10.4049/jimmunol.166.5.2907 |
0.316 |
|
| 2001 |
Leceta J, Gomariz RP, Martinez C, Abad C, Ganea D, Delgado M. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP. Annals of the New York Academy of Sciences. 921: 92-102. PMID 11193883 DOI: 10.1111/j.1749-6632.2000.tb06954.x |
0.345 |
|
| 2001 |
Delgado M, Leceta J, Sun W, Gomariz RP, Ganea D. VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expression. Annals of the New York Academy of Sciences. 921: 68-78. PMID 11193881 DOI: 10.1111/j.1749-6632.2000.tb06952.x |
0.438 |
|
| 2001 |
Delgado M, Ganea D. VIP and PACAP inhibit activation induced apoptosis in T lymphocytes. Annals of the New York Academy of Sciences. 921: 55-67. PMID 11193880 DOI: 10.1111/j.1749-6632.2000.tb06951.x |
0.317 |
|
| 2001 |
Delgado M, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3. Journal of Immunology (Baltimore, Md. : 1950). 166: 1028-40. PMID 11145682 DOI: 10.4049/jimmunol.166.2.1028 |
0.328 |
|
| 2001 |
Delgado M, Ganea D. VIP and PACAP inhibit Fas ligand-mediated bystander lysis by CD4(+) T cells. Journal of Neuroimmunology. 112: 78-88. PMID 11108936 DOI: 10.1016/S0165-5728(00)00414-8 |
0.319 |
|
| 2000 |
Delgado M, Ganea D. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Journal of Immunology (Baltimore, Md. : 1950). 165: 3051-7. PMID 10975815 DOI: 10.4049/jimmunol.165.6.3051 |
0.369 |
|
| 2000 |
Wang HY, Jiang XM, Ganea D. The neuropeptides VIP and PACAP inhibit IL-2 transcription by decreasing c-Jun and increasing JunB expression in T cells. Journal of Neuroimmunology. 104: 68-78. PMID 10683516 DOI: 10.1016/S0165-5728(99)00244-1 |
0.328 |
|
| 2000 |
Delgado M, Munoz-Elias EJ, Martinez C, Gomariz RP, Ganea D. VIP and PACAP38 modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines. Annals of the New York Academy of Sciences. 897: 401-14. PMID 10676466 DOI: 10.1111/J.1749-6632.1999.Tb07909.X |
0.345 |
|
| 2000 |
Delgado M, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression. Journal of Immunology (Baltimore, Md. : 1950). 164: 1200-10. PMID 10640731 DOI: 10.4049/jimmunol.164.3.1200 |
0.32 |
|
| 1999 |
Delgado M, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappaB and Ets activation. The Journal of Biological Chemistry. 274: 31930-40. PMID 10542221 DOI: 10.1074/jbc.274.45.31930 |
0.345 |
|
| 1999 |
Wang HY, Jiang X, Gozes I, Fridkin M, Brenneman DE, Ganea D. Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanisms Regulatory Peptides. 84: 55-67. PMID 10535409 DOI: 10.1016/S0167-0115(99)00068-3 |
0.317 |
|
| 1999 |
Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells. Journal of Neuroimmunology. 96: 167-81. PMID 10337915 DOI: 10.1016/S0165-5728(99)00023-5 |
0.328 |
|
| 1999 |
Jiang X, Wang HY, Yu J, Ganea D. VIP1 and VIP2 receptors but not PVR1 mediate the effect of VIP/PACAP on cytokine production in T lymphocytes. Annals of the New York Academy of Sciences. 865: 397-407. PMID 9928038 DOI: 10.1111/j.1749-6632.1998.tb11204.x |
0.353 |
|
| 1998 |
Delgado M, Munoz-Elias EJ, Kan Y, Gozes I, Fridkin M, Brenneman DE, Gomariz RP, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor α transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun Journal of Biological Chemistry. 273: 31427-31436. PMID 9813054 DOI: 10.1074/jbc.273.47.31427 |
0.321 |
|
| 1998 |
Martínez C, Delgado M, Pozo D, Leceta J, Calvo JR, Ganea D, Gomariz RP. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages. Journal of Leukocyte Biology. 63: 591-601. PMID 9581803 DOI: 10.1002/jlb.63.5.591 |
0.347 |
|
| 1998 |
Xin Z, Sun L, Ganea D. Vasoactive intestinal peptide stimulates p59fyn kinase activity in murine thymocytes. Peptides. 18: 1151-9. PMID 9396055 DOI: 10.1016/S0196-9781(97)00136-8 |
0.41 |
|
| 1997 |
Tang H, Sun L, Xin Z, Ganea D. Down-regulation of cytokine expression in murine lymphocytes by PACAP and VIP. Annals of the New York Academy of Sciences. 805: 768-78. PMID 8993475 DOI: 10.1111/j.1749-6632.1996.tb17555.x |
0.328 |
|
| 1996 |
Ganea D. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Advances in Neuroimmunology. 6: 61-74. PMID 8790782 DOI: 10.1016/S0960-5428(96)00007-1 |
0.424 |
|
| 1996 |
Tang H, Welton A, Ganea D. Neuropeptide regulation of cytokine expression: effects of VIP and Ro 25-1553. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 15: 993-1003. PMID 8590312 DOI: 10.1089/jir.1995.15.993 |
0.308 |
|
| 1993 |
Ganea D, Lei S. Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytes Journal of Neuroimmunology. 47: 147-158. PMID 8103776 DOI: 10.1016/0165-5728(93)90025-T |
0.318 |
|
| Show low-probability matches. |